v3.26.1
Statements of Changes in Shareholders’ Deficit - USD ($)
Ordinary Shares
Share Subscription Receivable
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at May. 22, 2024
Balance (in Shares) at May. 22, 2024        
Issuance of ordinary shares [1],[2] $ 986 34,014 35,000
Issuance of ordinary shares (in Shares) [1],[2] 9,857,143        
Net Income (Loss) (279,845) (279,845)
Balance at Dec. 31, 2024 $ 986 34,014 (279,845) (244,845)
Balance (in Shares) at Dec. 31, 2024 9,857,143        
Sale of 430,000 Private Placement Units $ 43 (1,100,000) 4,299,957 3,200,000
Sale of Private Placement Units (in Shares) 430,000        
Fair value of representative shares $ 23 23
Fair value of representative shares (in Shares) 230,000        
Fair value of rights included in Public Units 3,424,700 3,424,700
Allocated value of transaction costs to redeemable shares (147,830) (147,830)
Expenses paid by the Sponsor 649,078 649,078
Ordinary share issuance for no consideration [3] $ 20 1,995,980 1,996,000
Ordinary share issuance for no consideration (in Shares) [3] 200,000        
Share subscription receivable deemed uncollectible [4] 450,922 [3] [3] (450,922) [3] [3]
Share subscription receivable deemed uncollectible (in Shares) [4]        
Accretion and remeasurement for redeemable ordinary shares to redemption amount (9,606,821) (12,474,929) (22,081,750)
Net Income (Loss) 5,940,643 5,940,643
Balance at Dec. 31, 2025 $ 1,072 $ (7,265,053) $ (7,263,981)
Balance (in Shares) at Dec. 31, 2025 10,717,143        
[1] Includes an aggregate of up to 1,285,714 ordinary shares subject to surrender and forfeiture if the over-allotment option were not exercised in full by the underwriters (Note 5). In February 2025, the over-allotment option was exercised by the underwriters and these shares are no longer subject to forfeiture (Note 6).
[2] On November 6, 2024, the Sponsor surrendered and forfeited 12,503,968 ordinary shares to the Company for no consideration, following which the Sponsor held 9,857,143 ordinary shares. All share and per share data has been retrospectively presented.
[3] On March 11, 2025, the Company issued 200,000 ordinary shares for no consideration. See Note 7.
[4] Includes 45,092 ordinary shares subject to cancellation and surrender provisions as a result of the Sponsor defaulting on the share subscription receivable. The ordinary shares are presented as issued and outstanding until such time they are cancelled and surrendered. See Note 7.